Cargando…
The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients
BACKGROUND: Sepsis causes high mortality in vulnerable groups such as hematologic malignancy (HM) patients. There are various early warning scores of sepsis, eg, qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS). This study aimed to compare REWS, qSOFA, and SOFA in predicting severe complicati...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827160/ https://www.ncbi.nlm.nih.gov/pubmed/35153518 http://dx.doi.org/10.2147/OAEM.S345308 |
_version_ | 1784647570447925248 |
---|---|
author | Sricharoen, Pungkava Chueluecha, Chaithawat Yuksen, Chaiyaporn Jenpanitpong, Chetsadakon |
author_facet | Sricharoen, Pungkava Chueluecha, Chaithawat Yuksen, Chaiyaporn Jenpanitpong, Chetsadakon |
author_sort | Sricharoen, Pungkava |
collection | PubMed |
description | BACKGROUND: Sepsis causes high mortality in vulnerable groups such as hematologic malignancy (HM) patients. There are various early warning scores of sepsis, eg, qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS). This study aimed to compare REWS, qSOFA, and SOFA in predicting severe complications in hematologic malignancy patients visiting ED. METHODS: The study was conducted as a retrospective cohort study at the ED of Ramathibodi Hospital, Bangkok, Thailand. Adult HM patients suspected of sepsis and have visited ED between March 2016 and December 2019. RESULTS: Among 124 patients in our cohort, 51 (41%) had serious complication in ED and 20 (16%) died within 28 days after admission. The AUROCs of SOFA and qSOFA indicate significantly higher predicting in serious complication in ED than REWS (SOFA, 0.81 [95% CI, 0.73–0.89], qSOFA, 0.73 [95% CI, 0.65–0.81], REWS, 0.62 [95% CI, 0.52–0.72] p=0.004) while the predicting in 28-day mortality is not statistically significantly different (SOFA, 0.73 [95% CI, 0.60–0.85], qSOFA, 0.69 [95% CI, 0.58–0.80], REWS, 0.60 [95% CI, 0.44–0.75] p=0.25). CONCLUSION: The SOFA score is highest in predicting severe complications among hematologic malignancy patients. |
format | Online Article Text |
id | pubmed-8827160 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-88271602022-02-11 The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients Sricharoen, Pungkava Chueluecha, Chaithawat Yuksen, Chaiyaporn Jenpanitpong, Chetsadakon Open Access Emerg Med Original Research BACKGROUND: Sepsis causes high mortality in vulnerable groups such as hematologic malignancy (HM) patients. There are various early warning scores of sepsis, eg, qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS). This study aimed to compare REWS, qSOFA, and SOFA in predicting severe complications in hematologic malignancy patients visiting ED. METHODS: The study was conducted as a retrospective cohort study at the ED of Ramathibodi Hospital, Bangkok, Thailand. Adult HM patients suspected of sepsis and have visited ED between March 2016 and December 2019. RESULTS: Among 124 patients in our cohort, 51 (41%) had serious complication in ED and 20 (16%) died within 28 days after admission. The AUROCs of SOFA and qSOFA indicate significantly higher predicting in serious complication in ED than REWS (SOFA, 0.81 [95% CI, 0.73–0.89], qSOFA, 0.73 [95% CI, 0.65–0.81], REWS, 0.62 [95% CI, 0.52–0.72] p=0.004) while the predicting in 28-day mortality is not statistically significantly different (SOFA, 0.73 [95% CI, 0.60–0.85], qSOFA, 0.69 [95% CI, 0.58–0.80], REWS, 0.60 [95% CI, 0.44–0.75] p=0.25). CONCLUSION: The SOFA score is highest in predicting severe complications among hematologic malignancy patients. Dove 2022-02-05 /pmc/articles/PMC8827160/ /pubmed/35153518 http://dx.doi.org/10.2147/OAEM.S345308 Text en © 2022 Sricharoen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Sricharoen, Pungkava Chueluecha, Chaithawat Yuksen, Chaiyaporn Jenpanitpong, Chetsadakon The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients |
title | The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients |
title_full | The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients |
title_fullStr | The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients |
title_full_unstemmed | The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients |
title_short | The Use of qSOFA, SOFA, and Ramathibodi Early Warning Score (REWS) to Predict Severe Complications in Hematologic Malignancy Patients |
title_sort | use of qsofa, sofa, and ramathibodi early warning score (rews) to predict severe complications in hematologic malignancy patients |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827160/ https://www.ncbi.nlm.nih.gov/pubmed/35153518 http://dx.doi.org/10.2147/OAEM.S345308 |
work_keys_str_mv | AT sricharoenpungkava theuseofqsofasofaandramathibodiearlywarningscorerewstopredictseverecomplicationsinhematologicmalignancypatients AT chueluechachaithawat theuseofqsofasofaandramathibodiearlywarningscorerewstopredictseverecomplicationsinhematologicmalignancypatients AT yuksenchaiyaporn theuseofqsofasofaandramathibodiearlywarningscorerewstopredictseverecomplicationsinhematologicmalignancypatients AT jenpanitpongchetsadakon theuseofqsofasofaandramathibodiearlywarningscorerewstopredictseverecomplicationsinhematologicmalignancypatients AT sricharoenpungkava useofqsofasofaandramathibodiearlywarningscorerewstopredictseverecomplicationsinhematologicmalignancypatients AT chueluechachaithawat useofqsofasofaandramathibodiearlywarningscorerewstopredictseverecomplicationsinhematologicmalignancypatients AT yuksenchaiyaporn useofqsofasofaandramathibodiearlywarningscorerewstopredictseverecomplicationsinhematologicmalignancypatients AT jenpanitpongchetsadakon useofqsofasofaandramathibodiearlywarningscorerewstopredictseverecomplicationsinhematologicmalignancypatients |